![Bai Teng Zhao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 5 M $ al 31/07/2026
Bai Teng Zhao was the founder of ProfoundBio (Suzhou) Co., Ltd., established in 2018, and held the titles of Chairman & General Manager from 2018 to 2024.
Currently, Dr. Zhao is a Director at Piton Therapeutics Inc and an Independent Director at Whitehawk Therapeutics, Inc. since 2024.
Dr. Zhao completed undergraduate studies at Peking University and earned a doctorate from The University of Texas at Austin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/06/2026 | 1.250.000 ( 2,65 % ) | 5 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Director/Miembro de la Junta | 19/12/2024 |
Precidiag, Inc.
 Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
ProfoundBio (Suzhou) Co., Ltd.
 ProfoundBio (Suzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development of novel targeted therapeutics | Director Ejecutivo | 01/05/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProfoundBio (Suzhou) Co., Ltd.
ProfoundBio (Suzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development of novel targeted therapeutics | Commercial Services |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Precidiag, Inc.
Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
